Abstract
This study was aimed at developing a hydrophilic diethylenetriaminepentaacetic acid-tamoxifen (DTPA-Tam) analogue for use in imaging estrogen receptor positive (ER+) lesions. In rat uterine cytosol, the IC50 of DTPA-Tam conjugate was 1 μM and of tamoxifen, 2 μM. Biodistribution, autoradiography, and radionuclide imaging of 111In-DTPA-Tam in breast-tumor-bearing rats showed that tumor-to-tissue ratios increased steadily between 30 min and 48 h. The in vivo response of MCF-7 breast cancer xenografts to tamoxifen and DTPA-Tam in nude mice demonstrated that DTPA-Tam could reduce tumor growth rate. These results indicate that DTPA-Tam, a new hydrophilic ER+ ligand, might be useful in diagnosing ER+ lesions.
Original language | English (US) |
---|---|
Pages (from-to) | 553-559 |
Number of pages | 7 |
Journal | Journal of Pharmaceutical Sciences |
Volume | 85 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1996 |
ASJC Scopus subject areas
- Pharmaceutical Science